Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed on making and understanding biomaterial scaffolds for wound healing.

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

PRP helps skin heal, possibly through special cells called telocytes.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

The ABCA4 gene protects hair follicle stem cells from toxic vitamin A byproducts.

Maxillariinae orchids contain 62 compounds with potential health benefits, including treating skin conditions and diseases like cancer and diabetes.

Using one's own blood platelets and fat can improve facial and hair appearance without surgery.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Cultured dermal papilla cells can regenerate hair follicles and sustain hair growth.

EGF controls hair growth by regulating hair follicles' growth phases.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

HS patients rarely see dermatologists, often get opiates, and need better care.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Dupilumab for eczema may cause hair loss.

Immune cells affect hair growth and could lead to new hair loss treatments.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Denosumab treatment for osteoporosis can cause hair loss.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.